GH Optimization Stack

The GH Optimization Stack combines CJC-1295/Ipamorelin (upstream GH axis stimulation) with IGF-1 LR3 (downstream IGF-1 axis execution) to create a complete growth hormone axis protocol addressing both the signaling and execution phases of GH-mediated anabolism. CJC-1295/Ipamorelin stimulates the pituitary to release natural, pulsatile GH using two complementary receptor pathways for synergistic effect. This elevated GH pulse then signals the liver to produce IGF-1, which travels to muscle tissue where it activates satellite cells and promotes protein synthesis. IGF-1 LR3 amplifies this downstream phase by providing exogenous long-acting IGF-1 directly — bypassing the liver conversion step and delivering 20–30 hour half-life IGF-1 that saturates skeletal muscle receptors. Locally injected into the trained muscle immediately post-workout, it activates satellite cells at the exact site where muscle damage and repair are occurring. The combined effect: CJC/Ipa provides systemic, sustained GH elevation for anabolism, fat mobilization, and recovery. IGF-1 LR3 provides targeted satellite cell activation for muscle-specific hyperplasia — the creation of new muscle fibers, not just enlargement of existing ones.